HCC Patient Preferences in Japan

NCT02616692 · clinicaltrials.gov ↗

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Cancer

Interventions

DRUG: Hepatocellular Cancer (HCC) treatments including oral anti-cancer therapy [Nexavar (Sorafenib, BAY43-9006)]

Sponsor

Bayer